Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Multi-centre Randomised, Double Blind, Placebo Controlled Trial to Assess the Role of Intravenous Immunoglobulin in the Management of Children With Encephalitis

NCT02308982 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT02308982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02308982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Multi-centre Randomised, Double Blind, Placebo Controlled Trial to Assess the Role of Intravenous Immunoglobulin in the Management of Children With Encephalitis
Lead sponsor
University of Oxford
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2016
Completion date
September 30, 2022
Enrollment
18 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

encephalitis